Assembly Biosciences vs Wave Life Sciences
Assembly Biosciences is the larger business, with $72.3m of revenue in fiscal 2025 against $42.7m for Wave Life Sciences (1.7 times as much). Assembly Biosciences grew faster (153.5% against -60.5%). Assembly Biosciences kept more of each dollar of sales as profit: a net margin of -8.5% against -478.3%.
| Latest fiscal year | Assembly BiosciencesASMB, 2025 | Wave Life SciencesWVE, 2025 |
|---|---|---|
| Revenue | $72.3m | $42.7m |
| Revenue growth | 153.5% | -60.5% |
| Net income | −$6.1m | −$204m |
| Operating margin | -16.8% | — |
| Net margin | -8.5% | -478.3% |
| Return on equity | -5.1% | -56.2% |
| Free cash flow | −$41.2m | −$188m |
| Cash | $58.5m | $602m |
| Total debt | $0 | $0 |
| Debt to equity | 0.0% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | 317 |
| Market value | $392m | $707m |
| Price vs our value range | — | — |
| Moat score | 10 (Weak) | 8 (Weak) |
| Insider trades, 12 months | 0 buys, 5 sales | 6 buys, 46 sales |